Progyny, Inc.

NasdaqGS:PGNY 株式レポート

時価総額：US$2.6b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Progyny マネジメント

マネジメント 基準チェック /44

Progyny'sの CEO はPete Anevskiで、 Jan2022年に任命され、 の在任期間は 2.42年です。 の年間総報酬は$ 1.09Mで、 45.7%給与と54.3%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.014%を直接所有しており、その価値は$ 380.62K 。経営陣と取締役会の平均在任期間はそれぞれ2.4年と7.3年です。

主要情報

Pete Anevski

最高経営責任者

US$1.1m

報酬総額

CEO給与比率45.7%
CEO在任期間2.4yrs
CEOの所有権0.01%
経営陣の平均在職期間2.4yrs
取締役会の平均在任期間7.3yrs

経営陣の近況

Recent updates

Progyny: At This Price, Secular Tailwinds Are Too Compelling To Ignore

Jun 10

Progyny: No Change To Long-Term Outlook

Jun 04

Why We're Not Concerned About Progyny, Inc.'s (NASDAQ:PGNY) Share Price

Apr 29
Why We're Not Concerned About Progyny, Inc.'s (NASDAQ:PGNY) Share Price

Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)?

Apr 03
Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)?

Progyny: Long-Term Outlook Remains Positive, Reiterate Buy

Mar 15

Progyny: Long-Term Thesis Still Intact

Mar 09

Progyny's (NASDAQ:PGNY) Returns On Capital Are Heading Higher

Mar 01
Progyny's (NASDAQ:PGNY) Returns On Capital Are Heading Higher

Progyny, Inc.'s (NASDAQ:PGNY) P/E Still Appears To Be Reasonable

Jan 07
Progyny, Inc.'s (NASDAQ:PGNY) P/E Still Appears To Be Reasonable

Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Dec 11
Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

Nov 08
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Aug 24
Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

There's Been No Shortage Of Growth Recently For Progyny's (NASDAQ:PGNY) Returns On Capital

Aug 06
There's Been No Shortage Of Growth Recently For Progyny's (NASDAQ:PGNY) Returns On Capital

Progyny (NASDAQ:PGNY) Is Looking To Continue Growing Its Returns On Capital

May 06
Progyny (NASDAQ:PGNY) Is Looking To Continue Growing Its Returns On Capital

When Should You Buy Progyny, Inc. (NASDAQ:PGNY)?

Jan 25
When Should You Buy Progyny, Inc. (NASDAQ:PGNY)?

Progyny (NASDAQ:PGNY) Shareholders Will Want The ROCE Trajectory To Continue

Dec 12
Progyny (NASDAQ:PGNY) Shareholders Will Want The ROCE Trajectory To Continue

Is It Time To Consider Buying Progyny, Inc. (NASDAQ:PGNY)?

Oct 18
Is It Time To Consider Buying Progyny, Inc. (NASDAQ:PGNY)?

Progyny Stock Should Deliver Superior Returns For Investors

Aug 05

Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

Jul 27
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

At US$31.63, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely?

Jul 08
At US$31.63, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely?

Progyny: Solving Infertility Problem

Jul 05

Progyny Stock: A Hidden Gem Tackling Infertility

May 31

Investors Will Want Progyny's (NASDAQ:PGNY) Growth In ROCE To Persist

Apr 18
Investors Will Want Progyny's (NASDAQ:PGNY) Growth In ROCE To Persist

CEO報酬分析

Progyny の収益と比較して、Pete Anevski の報酬はどのように変化したか？
日付総報酬給与会社業績
Mar 31 2024n/an/a

US$61m

Dec 31 2023US$1mUS$500k

US$62m

Sep 30 2023n/an/a

US$52m

Jun 30 2023n/an/a

US$49m

Mar 31 2023n/an/a

US$43m

Dec 31 2022US$69mUS$500k

US$30m

Sep 30 2022n/an/a

US$42m

Jun 30 2022n/an/a

US$46m

Mar 31 2022n/an/a

US$56m

Dec 31 2021US$786kUS$425k

US$66m

Sep 30 2021n/an/a

US$90m

Jun 30 2021n/an/a

US$78m

Mar 31 2021n/an/a

US$58m

Dec 31 2020US$910kUS$425k

US$46m

Sep 30 2020n/an/a

US$3m

Jun 30 2020n/an/a

-US$10m

Mar 31 2020n/an/a

-US$5m

Dec 31 2019US$5mUS$375k

-US$9m

Sep 30 2019n/an/a

-US$6m

Jun 30 2019n/an/a

US$1m

Mar 31 2019n/an/a

-US$4m

Dec 31 2018US$682kUS$325k

-US$6m

報酬と市場: Peteの 総報酬 ($USD 1.09M ) は、 US市場 ($USD 6.76M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Peteの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Pete Anevski (57 yo)

2.4yrs

在職期間

US$1,093,512

報酬

Mr. Peter Anevski, also known as Pete, has been Chief Executive Officer and Director of Progyny, Inc. since January 2022 and had been its President since June 2019 until December 31, 2021 and was its Chief...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
David Schlanger
Executive Chairman7.3yrsUS$513.57k0.0056%
$ 145.2k
Peter Anevski
CEO & Director2.4yrsUS$1.09m0.014%
$ 365.3k
Michael Sturmer
President2.4yrsUS$1.49m0.070%
$ 1.8m
Mark Livingston
Chief Financial Officer3.8yrsUS$1.40m0.050%
$ 1.3m
Allison Swartz
Executive VP1.6yrsUS$546.22k0.015%
$ 384.1k
Steven Leist
Chief Technology Officerless than a yearデータなしデータなし
James Hart
Vice President of Investor Relationsno dataデータなしデータなし
Risa Fisher
Chief Marketing Officerno dataデータなしデータなし
Cassandra Pratt
Chief Human Resources Officerno dataデータなしデータなし
Julie Stadlbauer
Chief Business Development Officer2.4yrsデータなしデータなし
Janet Choi
Member of the Medical Advisory Board & Chief Medical Officer1.2yrsデータなしデータなし
Arielle Bogorad
Senior Vice President of Employer Market Strategy2.1yrsデータなしデータなし

2.4yrs

平均在職期間

57yo

平均年齢

経験豊富な経営陣: PGNYの経営陣は 経験豊富 であると考えられます ( 2.4年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
David Schlanger
Executive Chairman7.3yrsUS$513.57k0.0056%
$ 145.2k
Peter Anevski
CEO & Director2.4yrsUS$1.09m0.014%
$ 365.3k
Janet Choi
Member of the Medical Advisory Board & Chief Medical Officerno dataデータなしデータなし
Norman Payson
Independent Director7.5yrsUS$567.30k0.43%
$ 11.0m
Fred Cohen
Independent Director9.3yrsUS$583.35k0.013%
$ 327.3k
Beth Seidenberg
Lead Independent Director14.1yrsUS$653.39k0.27%
$ 7.0m
Kevin Gordon
Independent Director4.7yrsUS$518.30k0.0065%
$ 167.2k
Jeffrey Park
Independent Director4.7yrsUS$606.88k0.013%
$ 327.3k
Alan Copperman
Member of the Medical Advisory Boardno dataデータなしデータなし
Barry Behr
Member of Medical Advisory Boardno dataデータなしデータなし
Brad Kolb
Member of Medical Advisory Boardno dataデータなしデータなし
Gerard Letterie
Member of Medical Advisory Boardno dataデータなしデータなし

7.3yrs

平均在職期間

65yo

平均年齢

経験豊富なボード: PGNYの 取締役会 は 経験豊富 であると考えられます ( 7.3年の平均在任期間)。